| Mr Derrick Pratte Olzack, PA | |
|
1775 Third St, Atwater, CA 95301-3608 | |
| (209) 358-5611 | |
| (209) 358-0219 |
| Full Name | Mr Derrick Pratte Olzack |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1775 Third St, Atwater, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114456738 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 54432 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Derrick Pratte Olzack, PA 1775 3rd St, Atwater, CA 95301-3608 Ph: (209) 358-5611 | Mr Derrick Pratte Olzack, PA 1775 Third St, Atwater, CA 95301-3608 Ph: (209) 358-5611 |
News Archive
A drug approved by the Food and Drug Administration for melanoma in combination with a common cholesterol-lowering drug may show promise in controlling cancer growth in patients with non-small cell lung cancer (NSCLC), according to new research from the Icahn School of Medicine at Mount Sinai.
Scientists from Germany have determined the efficacy of currently used therapeutics in treating newer variants of SARS-CoV-2, including the UK, South Africa, and Brazil variants. Their findings reveal that both B.1.351 and B.1.1.248 variants are able to escape humoral immune responses induced by therapeutic antibodies, vaccinations, or natural SARS-CoV-2 infection.
BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in the Phase 1 clinical study of BMN 195, a small molecule utrophin upregulator, for the treatment of Duchenne muscular dystrohpy (DMD). Initial top-line results are expected in the third quarter of 2010.
Doctors at the North Shore-LIJ Health System on Saturday will present late-breaking data showing that an investigational drug Triferic is well tolerated and effective in treating iron deficiency in patients with chronic kidney disease undergoing dialysis.
Researchers at the Intermountain Medical Center Heart Institute in Salt Lake City have identified the first genetic mutation ever associated with a mysterious and potentially devastating form of heart disease that affects women in the final weeks of pregnancy or the first few months after delivery.
› Verified 8 days ago
Mrs. Velma E Macias, F.N.P Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1775 3rd St, Atwater, CA 95301 Phone: 209-358-5611 | |
Mr. Rodrigo Dezubiria, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3605 Hospital Rd, Atwater, CA 95301 Phone: 209-381-2000 Fax: 209-381-2010 | |
Dr. Tahir Yaqub, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1775 3rd St, Atwater, CA 95301 Phone: 209-358-5611 Fax: 209-358-0219 | |
Dr. Joerg Schuller, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1775 3rd St, Atwater, CA 95301 Phone: 209-358-5611 Fax: 209-358-0219 | |
Dr. William Earl Nation, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1775 3rd St, Atwater, CA 95301 Phone: 209-358-5611 Fax: 209-358-0219 | |
Dr. Steven L. Taggart, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1775 3rd St, Atwater, CA 95301 Phone: 209-358-5611 Fax: 209-358-0219 |